Australia markets closed
  • ALL ORDS

    7,689.70
    +69.50 (+0.91%)
     
  • AUD/USD

    0.7406
    -0.0014 (-0.19%)
     
  • ASX 200

    7,381.10
    +69.40 (+0.95%)
     
  • OIL

    83.26
    +0.98 (+1.19%)
     
  • GOLD

    1,766.70
    -1.60 (-0.09%)
     
  • BTC-AUD

    83,641.52
    +1,167.98 (+1.42%)
     
  • CMC Crypto 200

    1,448.27
    +73.05 (+5.31%)
     

BPH Energy Limited (BPH.AX) Investee Cortical lodges FDA

  • Oops!
    Something went wrong.
    Please try again later.
·2-min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.
BPH Energy Limited
BPH Energy Limited

BPH Energy Limited (BPH.AX) Investee Cortical lodges FDA

Perth, Australia, Oct 1, 2021 - (ABN Newswire) - Investee Cortical Dynamics Limited is pleased to announce that it has filed a 510(K) submission with the FDA in the USA for its medical device, the Brain Anaesthesia Response Monitor.

BARM(TM) takes a physiological approach to measuring the effects of anaesthetic drugs on brain electrical activity for surgical operations under General anaesthetic. The BARM(TM) algorithm is derived from a model of how human EEG (electrical activity of the brain) is generated. BARM(TM) describes the electrical activity of populations of excitatory and inhibitory neurons within the cerebral cortex, and uses established physiological parameters such as the number of connections between neuronal populations, conduction velocities, and firing rates and thresholds. The model can produce the main features of spontaneous human EEG and the effects general anaesthetics have on the EEG providing anaesthetists with valuable feedback as to the depth of anaesthesia experienced by patients.

Cortical Dynamics Limited was assisted in the FDA submission by MCRA, the leading U.S. Regulatory Advisor for the Medical Device and Biologics industries.

BARM(TM) is already CE, TGA and Korea MFDS regulated.


About BPH Energy Limited:


BPH Energy Limited (ASX:BPH) is an Australian Securities Exchange listed company developing biomedical research and technologies within Australian Universities and Hospital Institutes.

The company provides early stage funding, project management and commercialisation strategies for a direct collaboration, a spin out company or to secure a license.

BPH provides funding for commercial strategies for proof of concept, research and product development, whilst the institutional partner provides infrastructure and the core scientific expertise.

BPH currently partners with several academic institutions including The Harry Perkins Institute for Medical Research and Swinburne University of Technology (SUT).

Contact:

David Breeze
admin@bphenergy.com.au
www.bphenergy.com.au
T: +61 8 9328 8366

Source:
BPH Energy Limited

Copyright (C) 2021 ABN Newswire. All rights reserved.

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting